RecruitingOBSERVATIONAL

The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment

This study aims to understand the emotional impact of Gestational Trophoblastic Neoplasia (GTN) and its treatment on women in the UK. GTN is a rare condition that is usually curable, but it can be a challenging experience. We're talking to 20 women, between 6 weeks and 2 years after they finished chemotherapy, to hear directly about their experiences. We'll ask about any psychological effects, the support they received, and what could be improved. The goal is to help healthcare professionals better support women with GTN in the future, making sure their emotional needs are met after treatment.

At a glance

Status

Recruiting

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Enrolment target

Start

15 May 2024

Estimated completion

31 Dec 2025

Gestational Trophoblastic Neoplasia

What is this study about?

This research study is looking into how women feel emotionally and psychologically after going through chemotherapy for a condition called Gestational Trophoblastic Neoplasia (GTN). GTN is a rare but usually curable condition that can occur after pregnancy. Even though the physical illness is often successfully treated, the experience itself can be very challenging and have lasting effects on a woman's emotional well-being.

We want to talk to women who have completed their chemotherapy treatment for GTN to understand their personal experiences. This includes learning about any emotional difficulties they've faced, what kind of support they found helpful (or unhelpful), and whether they felt healthcare professionals provided enough psychological support during and after their treatment. By listening to these experiences, we hope to get a clearer picture of what it's truly like for women after GTN treatment in the UK.

The findings from this study are really important because they will help us identify any gaps in the current support provided to women. We aim to suggest ways to improve care in the future, ensuring that women who go through GTN treatment receive the best possible emotional and psychological support as they recover and move forward with their lives. The overall goal is to make sure that not only are women cured physically, but they also feel supported in their emotional recovery.

Key takeaways

Exploring the emotional impact of GTN after chemotherapy.
Aims to improve support for future GTN patients.
Involves a single phone interview to share experiences.
Looking for women who finished treatment 6 weeks to 2 years ago.
Study focused on understanding patient perspective.
Participation is voluntary and confidential.

Who may be eligible?

This study is looking for women who have been treated with chemotherapy for a condition called Gestational Trophoblastic Neoplasia (GTN). You would need to have finished your treatment between 6 weeks and 24 months ago. This means we're looking to speak with women who are no longer actively receiving chemotherapy but are still relatively recently finished with treatment.

You also need to be able to understand the study information and agree to take part freely. The study is for women aged between 16 and 55 years old.

Unfortunately, you wouldn't be able to take part if you finished your treatment very recently (less than 6 weeks ago) or a long time ago (more than 2 years ago). If you have any difficulties with understanding or communication, or if English is not your first language and you would have trouble participating in an interview in English, you would also not be eligible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Have you been treated with chemotherapy for GTN?
Did you finish your chemotherapy between 6 weeks and 24 months ago?
Are you aged between 16 and 55 years old?
Are you comfortable having an interview in English?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would have a single phone interview with the main researcher. This interview will be semi-structured, meaning there are some pre-prepared questions, but you'll also have the opportunity to share your experiences in your own words. The interview is expected to last for a comfortable amount of time, allowing you to tell your story fully. It will be digitally recorded to make sure all your valuable insights are captured accurately, and then written down word-for-word. There are no clinic visits, medications, or further follow-up appointments involved after your interview. Your total involvement would be the time taken for this single phone conversation.

Potential risks and benefits

Taking part in this study could offer you the benefit of sharing your personal experiences, which might be helpful for you and could contribute to improving care for other women in the future. There are very few risks involved; some people might find discussing their past experiences emotionally sensitive, but the interviewer will be understanding and supportive. You are always in control and can stop the interview at any time or choose not to answer any question you prefer not to. Your decision to participate is entirely voluntary, and you are free to withdraw from the study at any point without it affecting your current or future medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Weston Park Hospital
Verified postcode
Sheffield, United Kingdom· Recruiting

Common questions

What is Gestational Trophoblastic Neoplasia (GTN)?

GTN is a rare condition that can develop after pregnancy. It is usually successfully treated, often with chemotherapy.

How many women will be part of this study?

We plan to include 20 women in this study to gather detailed insights into their experiences.

What will happen with the information I share?

Your interview will be recorded and written down, and the information will be used to understand experiences and suggest improvements to care. Your identity will be kept confidential.

Will this study affect my ongoing medical care?

No, taking part in this study will not affect any medical care you are currently receiving or might receive in the future.

Do I have to take part if I'm contacted?

No, your participation is completely voluntary. You can choose not to take part or withdraw at any time without giving a reason.

How to find out more

Kamaljit Singh

kamaljitsingh@nhs.net 01142265274 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.